428 related articles for article (PubMed ID: 19540003)
1. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
2. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
Crouch PJ; Barnham KJ; Bush AI; White AR
Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
[TBL] [Abstract][Full Text] [Related]
5. Metal homeostasis in Alzheimer's disease.
White AR; Barnham KJ; Bush AI
Expert Rev Neurother; 2006 May; 6(5):711-22. PubMed ID: 16734519
[TBL] [Abstract][Full Text] [Related]
6. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
7. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
8. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
9. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
10. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
11. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
12. Metal chelator decreases Alzheimer beta-amyloid plaques.
Gouras GK; Beal MF
Neuron; 2001 Jun; 30(3):641-2. PubMed ID: 11430794
[TBL] [Abstract][Full Text] [Related]
13. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
Wang P; Wang ZY
Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
[TBL] [Abstract][Full Text] [Related]
14. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.
Di Vaira M; Bazzicalupi C; Orioli P; Messori L; Bruni B; Zatta P
Inorg Chem; 2004 Jun; 43(13):3795-7. PubMed ID: 15206857
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
16. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
Greenough MA; Camakaris J; Bush AI
Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
[TBL] [Abstract][Full Text] [Related]
17. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Crouch PJ; Barnham KJ
Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
20. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]